SCHEMBL15500067

SCHEMBL15500067

C=C/N=C1C(=C(/C)N)\C(=O)C=CN\1c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2-n2ccnn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 9/20 0.45
▸ NTRK1 P04629 6/20 0.41
▸ ALDH1A1 P00352 1/20 0.34
▸ PDGFRB P09619 3/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ IDH2 P48735 1/20 0.34
▸ RET P07949 1/20 0.33
▸ LTK P29376 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ NTRK3 Q16288 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ NTRK2 Q16620 1/20 0.33
▸ AURKB Q96GD4 1/20 0.33
▸ P2RY1 P47900 1/20 0.33
▸ BRAF P15056 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15500074 0.81 KDR (0.46) KDRNTRK1ALDH1A1PDGFRBIDH2
SCHEMBL15500072 0.73 KDR (0.47) KDRNTRK1ALDH1A1CA12CA1
SCHEMBL2335223 0.70 NTRK1 (0.51) KDRNTRK1ALDH1A1IDH2AURKB
SCHEMBL4922619 0.69 NTRK1 (0.54) KDRNTRK1ALDH1A1IDH2FLT3
SCHEMBL15500073 0.69 KDR (0.48) KDRNTRK1ALDH1A1PDGFRBIDH2
SCHEMBL4260345 0.69 KDR (0.49) KDRNTRK1ALDH1A1CA12CA1
SCHEMBL4260344 0.69 KDR (0.56) KDRNTRK1ALDH1A1CA12CA1
SCHEMBL28141722 0.68 NTRK1 (0.49) KDRNTRK1ALDH1A1IDH2
SCHEMBL2336030 0.68 KDR (0.68) KDRNTRK1MAPK14BRAF
SCHEMBL2333899 0.68 NTRK1 (0.51) KDRNTRK1PDGFRBRETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669274-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2014-03-11 — — US disclosed
Send feedback